Chongqing Pharscin Pharmaceutical Co Ltd (002907) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.000x

Based on the latest financial reports, Chongqing Pharscin Pharmaceutical Co Ltd (002907) has a cash flow conversion efficiency ratio of 0.000x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥833.94K ≈ $122.03K USD) by net assets (CN¥1.71 Billion ≈ $250.23 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 002907 company net worth for the company's overall valuation and market capitalisation.

Chongqing Pharscin Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how Chongqing Pharscin Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Chongqing Pharscin Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Chongqing Pharscin Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore 002907 operating cash flow to net income to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Standard Motor Products Inc NYSE:SMP	0.137x
Leshan Electric Power Co Ltd SHG:600644	0.062x
Amtran Technology Co Ltd TW:2489	-0.032x
Xvivo Perfusion AB ST:XVIVO	0.029x
Wuxi Delinhai Environmental Technology Co Ltd SHG:688069	-0.022x
V2 Retail Limited NSE:V2RETAIL	0.122x
Anhui Estone Materials Technology Co Ltd SHG:688733	-0.014x
Besalco Sa SN:BESALCO	0.062x

Annual Cash Flow Conversion Efficiency for Chongqing Pharscin Pharmaceutical Co Ltd (2013–2024)

The table below shows the annual cash flow conversion efficiency of Chongqing Pharscin Pharmaceutical Co Ltd from 2013 to 2024. View Chongqing Pharscin Pharmaceutical Co Ltd (002907) stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥1.66 Billion ≈ $242.91 Million	CN¥161.77 Million ≈ $23.67 Million	0.097x	-28.12%
2023-12-31	CN¥1.62 Billion ≈ $236.75 Million	CN¥219.34 Million ≈ $32.10 Million	0.136x	+1573.59%
2022-12-31	CN¥1.61 Billion ≈ $235.65 Million	CN¥13.04 Million ≈ $1.91 Million	0.008x	-87.62%
2021-12-31	CN¥1.27 Billion ≈ $185.24 Million	CN¥82.85 Million ≈ $12.12 Million	0.065x	-31.94%
2020-12-31	CN¥1.18 Billion ≈ $172.94 Million	CN¥113.64 Million ≈ $16.63 Million	0.096x	+56.20%
2019-12-31	CN¥1.07 Billion ≈ $156.69 Million	CN¥65.92 Million ≈ $9.65 Million	0.062x	+60.48%
2018-12-31	CN¥828.91 Million ≈ $121.30 Million	CN¥31.80 Million ≈ $4.65 Million	0.038x	-66.05%
2017-12-31	CN¥719.95 Million ≈ $105.35 Million	CN¥81.34 Million ≈ $11.90 Million	0.113x	-9.70%
2016-12-31	CN¥461.42 Million ≈ $67.52 Million	CN¥57.73 Million ≈ $8.45 Million	0.125x	-30.78%
2015-12-31	CN¥365.71 Million ≈ $53.51 Million	CN¥66.10 Million ≈ $9.67 Million	0.181x	+167.95%
2014-12-31	CN¥299.77 Million ≈ $43.87 Million	CN¥20.22 Million ≈ $2.96 Million	0.067x	-65.66%
2013-12-31	CN¥240.97 Million ≈ $35.26 Million	CN¥47.34 Million ≈ $6.93 Million	0.196x	--

About Chongqing Pharscin Pharmaceutical Co Ltd

SHE:002907 China Drug Manufacturers - Specialty & Generic

Market Cap

$829.84 Million

CN¥5.67 Billion CNY

Market Cap Rank

#9784 Global

#2520 in China

Share Price

CN¥13.58

Change (1 day)

+2.41%

52-Week Range

CN¥11.69 - CN¥17.34

All Time High

CN¥42.89